Obvious?
Ok, I will try to explain.
What is obvious to you is different than what is obvious to me. We are not talking about news (although I think the official name and ticker change will be news to a lot of people.)
Its about visibility and a uniform distribution of information through brokers and 3rd party market data providers.
Take ihub. The AEPP message board has been an outstanding source of information due to the efforts of many posters who have shared their time and research.
But if you look at ihub AEPP financials tab, Mr. Andrew S. Mynheer is still listed here as CEO without any mention of the SPA completion in April and Redman becoming the new CEO.
Many of us here have been here since before the SPA completion (including critics). I am not seeing a PR for that anywhere in market feeds.
That was early April.
In the several months following that transaction, there has been a lot of DD shared by several people, including the history of Oncolix, accredited investment and corporate presentations.
We have been discussing the potential of Oncolix for roughly 6 months.
I cant speak to what you are seeing, but from my perspective, not much of this info is known to the overall market.
My broker only recently picked up the news feed and still has not made any updates to the name, ticker or corporate profile description and wont until FINRA.
The third party data providers haven’t either with the exception of quotemedia and their clients who have made the name change ahead of the ticker change.
The only update I saw from my broker was the change of address shortly after the SPA.
The FINRA update will provide a lot of old news and information that is already known to ihub posters, to a much larger pool of investors.
I cant say that the increased visibility of Oncolix will cause the stock to go higher, but I also don’t believe that the completion of the reverse merger is already “priced in.”
Sorry for the long post.
IMO and FWIW.
AI
